Phibro Animal Health and Epitopix LLC Enter into Partnership21 November 2013
US - Phibro Animal Health Corporation and Epitopix have entered into a partnership to manufacture and market biological products for chickens in the United States based on Epitopix’s novel SRP® technology.
Additionally, the parties intend to collaborate on a global basis to develop unique poultry biological products based on this technology.
"We are very excited about combining the novel technology and experience of Epitopix with Phibro’s global expertise in developing innovative poultry vaccines, supported in the field by Phibro’s sales and technical service team. Our two companies share very similar values and cultures, which makes this partnership an ideal fit," said Larry Miller, President, Phibro Animal Health.
"We are delighted to have this opportunity to commercialize our SRP technology in the poultry market. This partnership will help poultry producers access a superior immunological solution for control of salmonella, E. coli and other gram-negative pathogens," said Jim Sandstrom, DVM, General Manager, Epitopix, LLC.
ThePoultrySite News Desk